November 2, 2024

How a Tangled Protein Kills Brain Cells, Promotes Alzheimer’s Disease

Irregular levels of beta-amyloid protein in the brain kind plaques (brown in this illustration) in between nerve cells, disrupting cells. Tau protein can form tangles (blue) within neurons, hurting neural communication. Credit” National Institute on Aging, NIH
Look deep inside the brain of someone with Alzheimers illness, many kinds of dementia or the concussion-related syndrome called chronic traumatic encephalopathy (CTE) and youll find a common presumed offender: stringy, hairball-like tangles of a protein called tau.
Such conditions, jointly known as “tauopathies” strike scores of individuals around the world, with Alzheimers alone affecting six million people in the United States.
More than a century after German psychiatrist Alois Alzheimer discovered tau tangles, scientists still have much to discover about them.

A University of Colorado Boulder research study, released in the journal Neuron, reveals for the very first time that tau aggregates demolish RNA, or ribonucleic acid, inside cells and hinder an integral mechanism called splicing, by which cells eventually produce necessary proteins.
” Understanding how tau causes neurodegeneration is the crux of not just comprehending Alzheimers illness however also multiple other neurological illness,” stated senior author Roy Parker, a professor of biochemistry and director of the BioFrontiers Institute at CU Boulder. “If we can understand what it does and how it goes bad in illness we can develop new therapies for conditions that now are mainly untreatable.”
The study was led by Evan Lester, an M.D./ PhD candidate in the Medical Scientist Training Program, which enables students to simultaneously work towards a medical degree from the University of Colorado Anschutz Medical Campus and a PhD from CU Boulder.
For part of his medical training, Lester worked alongside medical professionals and patients at the CU Alzheimers and Cognition Center in Aurora, seeing up close how critically more research is needed.
” There is absolutely nothing we can do for these patients today– no illness modifying-treatments for Alzheimers or many of the other tauopathies,” Lester said, noting that 70% of neurodegenerative diseases are believed to be a minimum of partly associated to tau aggregates.
For the research study, the scientists separated tau aggregates from cell lines and from the brains of mice with an Alzheimers- like condition. They utilized hereditary sequencing techniques to determine what was inside.
They confirmed for the first time that tau aggregates consist of RNA, or ribonucleic acid, a single-stranded molecule secret for synthesizing proteins in cells. They recognized what sort of RNA it is, specifically snRNA, or little nuclear RNA, and snoRNA, or small nucleolar RNA.
They also discovered that tau communicates with pieces of cellular equipment referred to as nuclear speckles, sequestering and displacing proteins inside them and interrupting a procedure called RNA splicing in which the cell weeds out unneeded product to generate new, healthy RNA.
” The tau aggregates seem sequestering splicing-related RNA and proteins, disrupting their normal function and hindering the cells ability to make proteins,” said Lester.
Significantly, researchers examining the brains of Alzheimers patients after death have actually discovered evidence of splicing-related problems in cells.
Already, numerous business have clinical trials in progress testing drugs that would do away with tau entirely in patients with neurodegenerative diseases. That might possibly have unintended consequences, said Lester.
” A big issue in the field is that nobody really knows what tau does in healthy people and It likely has crucial functions when not in tangles,” he stated.
By better understanding specifically what it does to damage and eliminate cells, Parker and Lester hope to bring a different approach to the table.
” The idea would be to intervene in the abnormal functions while protecting the typical functions of tau,” Lester said.
While its unlikely his existing clients will benefit from his discovery, at some point his future clients simply might.
Referral: “Tau aggregates are RNA-protein assemblies that mislocalize multiple nuclear speckle parts” by Evan Lester, Felicia K. Ooi, Nadine Bakkar, Jacob Ayers, Amanda L. Woerman, Joshua Wheeler, Robert Bowser, George A. Carlson, Stanley B. Prusiner and Roy Parker, 12 April 2021, Neuron.DOI: 10.1016/ j.neuron.2021.03.026.